Latest Breaking News On - Bruce mazer - Page 8 : comparemela.com

EpiVax Demonstrates Antigen-Specific Tolerance Induction in Allergy with Tregitopes, Results Published in Frontiers in Immunology Frontiers in Immunology. This research highlights Tregitopes as a promising therapy for allergy. Administration of IgG-derived Tregitopes were found to induce suppressive antigen-specific T-regulatory cells in ovalbumin (OVA) and ragweed-allergic murine mouse models, attenuating allergen-induced airway hyperresponsiveness and lung inflammation. Tregitopes are peptides found in human immunoglobulin which were first discovered in 2008 by Dr. Anne De Groot and William Martin. EpiVax has since validated many more Tregitopes and has developed a strong Tregitope patent estate. With a wide range of therapeutic applications, Tregitopes can be co-formulated or fused to proteins to induce antigen-specific tolerance. EpiVax is currently licensing Tregitope with commercial and academic partners. More information on the EpiVax Tregitope Platform is available here.

Bruce mazerKostenloser wertpapierhandelWilliam martinSamir massoudMarieme dembeleKatie porterResearch instituteAdministration of tregitopesPrnewswire epivax incMcgill universityMcgill university health centreBusiness developmentImprove asthmaPromoting highly suppressiveIgg derived tregitopesAnne de groot